Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs1057519847
rs1057519847
0.040 GeneticVariation BEFREE Cytoplasmic ERβ1 expression is associated with survival of patients with Stage IV lung adenocarcinoma and an EGFR mutation at exon 21 L858R subsequent to treatment with EGFR-TKIs. 31289556

2019

dbSNP: rs1057519848
rs1057519848
0.040 GeneticVariation BEFREE Cytoplasmic ERβ1 expression is associated with survival of patients with Stage IV lung adenocarcinoma and an EGFR mutation at exon 21 L858R subsequent to treatment with EGFR-TKIs. 31289556

2019

dbSNP: rs121434568
rs121434568
0.040 GeneticVariation BEFREE Cytoplasmic ERβ1 expression is associated with survival of patients with Stage IV lung adenocarcinoma and an EGFR mutation at exon 21 L858R subsequent to treatment with EGFR-TKIs. 31289556

2019

dbSNP: rs1057519847
rs1057519847
0.040 GeneticVariation BEFREE A 65-year-old Japanese woman was diagnosed with stage IV lung adenocarcinoma with L858R point mutation in exon 21. 29675860

2018

dbSNP: rs1057519848
rs1057519848
0.040 GeneticVariation BEFREE A 65-year-old Japanese woman was diagnosed with stage IV lung adenocarcinoma with L858R point mutation in exon 21. 29675860

2018

dbSNP: rs121434568
rs121434568
0.040 GeneticVariation BEFREE A 65-year-old Japanese woman was diagnosed with stage IV lung adenocarcinoma with L858R point mutation in exon 21. 29675860

2018

dbSNP: rs1057519847
rs1057519847
0.040 GeneticVariation BEFREE We report a case of a 38-year-old woman who was diagnosed with stage IV lung adenocarcinoma, harboring an epidermal growth factor receptor (EGFR) L858R mutation on exon 21 and a T790 M mutation on exon 20. 27599705

2017

dbSNP: rs1057519848
rs1057519848
0.040 GeneticVariation BEFREE We report a case of a 38-year-old woman who was diagnosed with stage IV lung adenocarcinoma, harboring an epidermal growth factor receptor (EGFR) L858R mutation on exon 21 and a T790 M mutation on exon 20. 27599705

2017

dbSNP: rs121434568
rs121434568
0.040 GeneticVariation BEFREE We report a case of a 38-year-old woman who was diagnosed with stage IV lung adenocarcinoma, harboring an epidermal growth factor receptor (EGFR) L858R mutation on exon 21 and a T790 M mutation on exon 20. 27599705

2017

dbSNP: rs1057519847
rs1057519847
0.040 GeneticVariation BEFREE Patients in stage IV lung adenocarcinoma with MPEs at initial diagnosis have shorter overall survival and higher EGFR mutation rate, especially for L858R, than patients who develop MPEs following disease progression. 23018906

2013

dbSNP: rs1057519848
rs1057519848
0.040 GeneticVariation BEFREE Patients in stage IV lung adenocarcinoma with MPEs at initial diagnosis have shorter overall survival and higher EGFR mutation rate, especially for L858R, than patients who develop MPEs following disease progression. 23018906

2013

dbSNP: rs121434568
rs121434568
0.040 GeneticVariation BEFREE Patients in stage IV lung adenocarcinoma with MPEs at initial diagnosis have shorter overall survival and higher EGFR mutation rate, especially for L858R, than patients who develop MPEs following disease progression. 23018906

2013

dbSNP: rs149248025
rs149248025
0.010 GeneticVariation BEFREE A 74-year-old woman was diagnosed with stage IV lung adenocarcinoma with EGFR L868R mutation 2 years before presentation.Gefitinib, an EGFR-TKI was started. 30868686

2019

dbSNP: rs121913444
rs121913444
0.010 GeneticVariation BEFREE We present the case of a 68-year-old man with stage IV lung adenocarcinoma with an uncommon EGFR mutation in exon 21 (L861Q). 29866661

2018

dbSNP: rs397517096
rs397517096
0.010 GeneticVariation BEFREE A Chinese woman diagnosed with stage IV lung adenocarcinoma harbored a rare EGFR L747P (2239-2240 TT > CC) mutation, and treatment with gefitinib and osimertinib failed to achieve the desired effect. 29673089

2018